相关实验视频

Updated: Jul 2, 2025

Organotypic Slice Cultures as Preclinical Models of Tumor Microenvironment in Primary Pancreatic Cancer and Metastasis

Organotypic Slice Cultures as Preclinical Models of Tumor Microenvironment in Primary Pancreatic Cancer and Metastasis

Published on: June 22, 2021

胰腺癌微环境的临床评估:机遇和挑战

Julianne M Szczepanski¹, Mark A Rudolf¹, Jiaqi Shi¹

¹Department of Pathology and Clinical Labs, University of Michigan, Ann Arbor, MI 48109, USA.

|February 24, 2024

概括

了解胰腺癌 (PDAC) 和其瘤微环境 (TME) 可以改善患者的治疗. 目前的TME评估方法需要进步,以匹配个性化癌症遗传学,从而实现新的治疗方法.

科学领域:

在瘤学瘤学.
癌症生物学癌症生物学
免疫学免疫学免疫学

背景情况:

胰腺管道腺癌 (PDAC) 的诊断和治疗正在得到改善.
瘤微环境 (TME) 显著影响PDAC进展和治疗反应.
目前的TME评估方法不如癌细胞遗传分析那么先进.

研究的目的:

审查目前PDAC诊断和管理的协议.
讨论PDAC及其TME的新生物标志物.
突出评估PDAC TME新疗法的机遇和挑战.

主要方法:

对PDAC诊断和管理协议的文献综述.
对PDAC和TME新兴生物标志物的审查.
分析TME评估中的挑战和机遇.

主要成果:

虽然PDAC治疗正在取得进展,但TME评估仍落后于基因分析.
在患者内部和患者之间,TME是异质的.
新型生物标志物和TME导向疗法显示出有前途.

结论:

了解PDAC及其TME的进展对于治疗转型至关重要.
标准化TME评估对于新疗法的临床转化至关重要.
解决TME异质性是开发有效PDAC治疗的关键.

关键词:

生物标志物生物标志物管理的管理管理的管理.胰腺管道腺癌瘤病理学的病理学瘤微环境是一个微环境.

更多相关视频

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment: